KIMBERLY COGGINS: Open Payments
NPI 1942845045 · ST JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 9 payments from 8 companies in 2025. Trend: 2023 $15 · 2024 $140 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| PFIZER INC. | 1 | $23 |
| Boston Scientific Corporation | 1 | $18 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: BREZTRI, ELIQUIS, OverStitch Endoscopic Suturing System, MOUNJARO, SHINGRIX, GARDASIL 9, Rybelsus.
Industry payments across FL — which companies pay providers there.
